Lakewood-Amedex Biotherapeutics Inc. (LABT) stock
Close on Nov 12, 2026Market cap $851.19KP/E –Yield –
Lakewood-Amedex Biotherapeutics statistics
35 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.20
- 2.29
Share statisticsIndustry
- Shares Change (QoQ)
- -69.2%
- 0.51%
- Shares Held by Institutions
- 4.13%
- 56.4%
Short sellingIndustry
- Short Interest
- 152,917
- –
- Short Interest Change
- 69.8%
- -0.76%
- Short % of Shares Outstanding
- 6.45%
- 6.30%
- Days to Cover
- 1.00
- 5.13
Stock price statisticsIndustry
- 20-Day Moving Average
- $0.37
- –
- 50-Day Moving Average
- $1.03
- –
- Average True Range (14)
- $0.13
- –
- Price Change (1 Week)
- -33.6%
- 1.51%
- Price Change (1 Month)
- -43.1%
- -2.35%
- Price Change (3 Months)
- -84.2%
- -21.1%
- Price Change (6 Months)
- -98.2%
- -22.6%
- Average Volume (10 Days)
- 82M
- –
- Average Volume (20 Days)
- 45M
- –
- Average Volume (90 Days)
- 12M
- –
- Relative Volume
- 0.10
- 0.79
- Relative Strength Index (14)
- 38.0
- 44.7
- Volatility (1 Year)
- 325.0%
- 80.4%
Financial positionIndustry
- Current Ratio
- 7.70
- 3.30
- Quick Ratio
- 7.29
- 2.42
Balance sheetIndustry
- Net Cash (Debt)
- $4.58M
- $17.46M
- Net Cash Per Share
- $1.93
- $0.72
- Equity (Book Value)
- $4.33M
- $53.27M
- Book Value Per Share
- $1.83
- $1.50
- Tangible Book Value
- $4.33M
- $26.82M
- Working Capital
- $4.22M
- $79.47M
Taxes and interestIndustry
- Interest Expense
- $1.32K
- $2.93M
Scores and fair valueIndustry
- Altman Z-Score
- -17.54
- 0.30
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | LABT | S&P 500 | Difference | LABT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -50.9% | -2.7% | −48.2 pts | ||
| 3 months | -84.8% | -1.7% | −83.0 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M LABT shares were sold short on Oct 30, 2026, up 69.8% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 60.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 152,917 | +69.8% | 6,760,367 | 1.0 |
| Oct 15, 2026 | 90,040 | -31.1% | 874,150 | 1.0 |
| Sep 30, 2026 | 130,722 | +146.8% | 3,343,756 | 1.0 |
| Sep 15, 2026 | 52,967 | -13.7% | 1,003,484 | 1.0 |
| Aug 31, 2026 | 61,402 | +9.2% | 1,355,337 | 1.0 |
| Aug 14, 2026 | 56,253 | -55.4% | 140,397 | 1.0 |
| Jul 31, 2026 | 126,080 | +424.7% | 6,655,441 | 1.0 |
| Jul 15, 2026 | 24,029 | -36.4% | 379,127 | 1.0 |
| Jun 30, 2026 | 37,772 | -48.4% | 299,767 | 1.0 |
| Jun 15, 2026 | 73,164 | +87.5% | 362,400 | 1.0 |
| May 29, 2026 | 39,018 | -73.7% | 4,357,454 | 1.0 |
| May 15, 2026 | 148,551 | +96.2% | 4,358,327 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?